Christoph Sven Hoffmann
Président chez Sallfort Privatbank AG
Profil
Christoph Sven Hoffmann is currently the Chairman-Supervisory Board at Sallfort Privatbank AG and a Director at Esocap AG.
Previously, he held positions as a Director at Molecular Health, Inc., an Independent Director at Eastpharma Ltd., and as a Regional Manager at Roche Hong Kong Ltd.
He is a graduate of the University of Basel.
Postes actifs de Christoph Sven Hoffmann
| Sociétés | Poste | Début |
|---|---|---|
Sallfort Privatbank AG
 Sallfort Privatbank AG Regional BanksFinance Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland. | Président | - |
Esocap AG
 Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christoph Sven Hoffmann
| Sociétés | Poste | Fin |
|---|---|---|
| Roche Hong Kong Ltd. | Corporate Officer/Principal | 01/01/1991 |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | - |
| EASTPHARMA LTD. | Directeur/Membre du Conseil | - |
Formation de Christoph Sven Hoffmann
| University of Basel | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Eastpharma Ltd.
 Eastpharma Ltd. Pharmaceuticals: MajorHealth Technology Eastpharma Ltd. is a holding company, which engages in the production of pharmaceutical products. It operates through the following segments: Production and Sale of Human Pharmaceuticals, Veterinary Products, and Other. The Human Pharmaceuticals segment sells branded generic and licensed products; and manufactures and offers antibiotic active ingredients and empty ampoules. The Veterinary Products segment provides veterinary drugs and agrochemicals. The Other segment produces and sells cologne. The company was founded on August 17, 2006 and is headquartered in Hamilton, Bermuda. | Health Technology |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Technology Services |
Sallfort Privatbank AG
Sallfort Privatbank AG Regional BanksFinance Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland. | Finance |
| Roche Hong Kong Ltd. | |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Health Technology |
